Routine Paediatric Sickle Cell Disease (SCD) Outpatient Care in a Rural Kenyan Hospital: Utilization and Costs

被引:9
作者
Amendah, Djesika D. [1 ]
Mukamah, George [2 ]
Komba, Albert [2 ]
Ndila, Carolyne [2 ]
Williams, Thomas N. [2 ,3 ,4 ,5 ]
机构
[1] African Populat Hlth Res Ctr, Nairobi, Kenya
[2] Ctr Geog Med Res Coast, Kenya Med Res Inst KEMRI, Kilifi, Kenya
[3] INDEPTH Network Demog Surveillance Sites, Accra, Ghana
[4] Univ Oxford, Nuffield Dept Med, Oxford, England
[5] Global Network Sickle Cell Dis, Toronto, ON, Canada
来源
PLOS ONE | 2013年 / 8卷 / 04期
基金
英国惠康基金;
关键词
HEALTH-CARE; CHILDREN; EXPENDITURES; PROGRAM; COHORT; ADULTS;
D O I
10.1371/journal.pone.0061130
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: More than 70% of children with sickle cell disease (SCD) are born in sub-Saharan Africa where the prevalence at birth of this disease reaches 2% or higher in some selected areas. There is a dearth of knowledge on comprehensive care received by children with SCD in sub-Saharan Africa and its associated cost. Such knowledge is important for setting prevention and treatment priorities at national and international levels. This study focuses on routine care for children with SCD in an outpatient clinic of the Kilifi District Hospital, located in a rural area on the coast of Kenya. Objective: To estimate the per-patient costs for routine SCD outpatient care at a rural Kenyan hospital. Methods: We collected routine administrative and primary cost data from the SCD outpatient clinic and supporting departments at Kilifi District Hospital, Kenya. Costs were estimated by evaluating inputs - equipment, medication, supplies, building use, utility, and personnel - to reflect the cost of offering this service within an existing healthcare facility. Annual economic costs were similarly calculated based on input costs, prorated lifetime of equipment and appropriate discount rate. Sensitivity analyses evaluated these costs under different pay scales and different discount rate. Results: We estimated that the annual economic cost per patient attending the SCD clinic was USD 138 in 2010 with a range of USD 94 to USD 229. Conclusion: This study supplies the first published estimate of the cost of routine outpatient care for children born with SCD in sub-Saharan Africa. Our study provides policy makers with an indication of the potential future costs of maintaining specialist outpatient clinics for children living with SCD in similar contexts.
引用
收藏
页数:6
相关论文
共 45 条
  • [21] Antibiotic Utilization and Prophylaxis in Paediatric Cardiac Surgery: A Retrospective Observational Study at a Rural Tertiary Care Hospital in India
    Pathan, Sohilkhan R.
    Bhende, Vishal V.
    Sharma, Tanishq S.
    Kumar, Amit
    Patel, Vishal A.
    Sharma, Kruti B.
    Pandya, Shivangi B.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [22] Patients with sickle cell disease and suspected COVID-19 in a paediatric intensive care unit
    Heilbronner, Claire
    Berteloot, Laureline
    Tremolieres, Pierre
    Dupic, Laurent
    Saint Blanquat, Laure de
    Lesage, Fabrice
    Odievre, Marie-Helene
    Marcellus, Charles
    Fourgeaud, Jacques
    Montalembert, Marianne de
    Grimaud, Marion
    Moulin, Florence
    Renolleau, Sylvain
    Allali, Slimane
    Oualha, Mehdi
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (01) : E21 - E24
  • [23] Dissatisfaction With Hospital Care for Children With Sickle Cell Disease Not Due Only to Race and Chronic Disease
    Brousseau, David C.
    Mukonje, Terence
    Brandow, Amanda M.
    Nimmer, Mark
    Panepinto, Julie A.
    PEDIATRIC BLOOD & CANCER, 2009, 53 (02) : 174 - 178
  • [24] Characteristics of Acute Care Utilization of a Delaware Adult Sickle Cell Disease Patient Population
    Anderson, Nina
    Bellot, Jennifer
    Senu-Oke, Oluseyi
    Ballas, Samir K.
    POPULATION HEALTH MANAGEMENT, 2014, 17 (01) : 60 - 65
  • [25] Assessment of transition readiness to predict health care utilization during transition to adult care in sickle cell disease
    Howell, Kristen E.
    Heitzer, Andrew M.
    Longoria, Jennifer N.
    Potter, Brian
    Wang, Winfred C.
    Anderson, Sheila
    Kang, Guolian
    Hankins, Jane S.
    Porter, Jerlym S.
    EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (12) : 1063 - 1072
  • [26] Acute care utilization among individuals with sickle cell disease and related cardiopulmonary and renal complications
    Singh, Ashima
    Brousseau, David C.
    Dasgupta, Mahua
    Shet, Arun S.
    Field, Joshua J.
    Brandow, Amanda M.
    PLOS ONE, 2024, 19 (04):
  • [27] Social and Behavioral Factors in Sickle Cell Disease: Employment Predicts Decreased Health Care Utilization
    Williams, Hants
    Silva, Susan
    Cline, David
    Freiermuth, Caroline
    Tanabe, Paula
    JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 2018, 29 (02) : 814 - 829
  • [28] Sickle-Cell Disease Co-Management, Health Care Utilization, and Hydroxyurea Use
    Crego, Nancy
    Douglas, Christian
    Bonnabeau, Emily
    Earls, Marian
    Eason, Kern
    Merwin, Elizabeth
    Rains, Gary
    Tanabe, Paula
    Shah, Nirmish
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2020, 33 (01) : 91 - 105
  • [29] Cardiac Manifestations in Adult Sickle Cell Disease Patients at a Tertiary Care Hospital in Chhattisgarh, India
    Shrivastava, Smit
    Chaudhary, Animesh
    Pandey, Prabhat
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2021, 10 (21): : 1567 - 1574
  • [30] Opioid doses and acute care utilization outcomes for adults with sickle cell disease: ED versus acute care unit
    Molokie, Robert E.
    Montminy, Chariz
    Dionisio, Corissa
    Farooqui, Muhammad Ahmen
    Gowhari, Michel
    Yao, Yingwei
    Suarez, Marie L.
    Ezenwa, Miriam O.
    Schlaeger, Judith M.
    Wang, Zaijie J.
    Wilkie, Diana J.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2018, 36 (01) : 88 - 92